Issued Patents All Time
Showing 1–25 of 43 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12351561 | Crystalline (2S,4R)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof | Adam D. Hughes, Melissa Fleury, Miroslav Rapta, R. Michael Baldwin, David L. Bourdet | 2025-07-08 |
| 11795180 | Formulation of a pan-JAK inhibitor | Bernardus Joseph Nitert, Yvonne Rosiaux, Marian E. Van Der Veen, Nathan Schulpen, Jens Maes +2 more | 2023-10-24 |
| 11780852 | Methods for treating Crohn's disease using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile | Ryan Hudson, Jennifer Kozak, Dante D. Podesto, Xiaojun Huang | 2023-10-10 |
| 11718591 | Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2- methylpentanoic acid and uses thereof | Adam D. Hughes, Melissa Fleury, Miroslav Rapta, Gene Timothy Fass, Michael Simeone +2 more | 2023-08-08 |
| 11718616 | JAK kinase inhibitor compounds for treatment of respiratory disease | Paul R. Fatheree, John R. Jacobsen, Anne-Marie Beausoleil, Gary E. L. Brandt, Melissa Fleury +9 more | 2023-08-08 |
| 11642332 | (2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid | Melissa Fleury, Adam D. Hughes, Anne-Marie Beausoleil, Erik Fenster, Miroslav Rapta | 2023-05-09 |
| 11452723 | Combination dosage form of a mu opioid receptor antagonist and an opioid agent | Shaoling Li, Manshiu Leung, Hao Zhang, Yun Mo | 2022-09-27 |
| 11230536 | Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof | Adam D. Hughes, Melissa Fleury, Miroslav Rapta | 2022-01-25 |
| 11160810 | Fused imidazo-piperidine JAK inhibitor compound | Robert Murray McKinnell, Hao Zhang, Paul R. Fatheree, Lan Jiang, Marta Dabros +1 more | 2021-11-02 |
| 11160800 | Methods of treatment using a JAK inhibitor compound | Hao Zhang | 2021-11-02 |
| 11033533 | (2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid | Melissa Fleury, Adam D. Hughes, Anne-Marie Beausoleil, Erik Fenster, Miroslav Rapta | 2021-06-15 |
| 10968205 | Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors | Robert Murray McKinnell, Erik Fenster, Tom M. Lam, Jerry Nzerem, Marta Dabros +1 more | 2021-04-06 |
| 10947254 | Methods for treating ulcerative colitis using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile | Ryan Hudson, Jennifer Kozak, Dante D. Podesto, Xiaojun Huang | 2021-03-16 |
| 10946009 | Combination dosage form of a mu opioid receptor antagonist and an opioid agent | Shaoling Li, Manshiu Leung, Hao Zhang, Yun Mo | 2021-03-16 |
| 10913740 | JAK kinase inhibitor compounds for treatment of respiratory disease | Paul R. Fatheree, John R. Jacobsen, Gary E. L. Brandt, Noah Benjamin, Marta Dabros | 2021-02-09 |
| 10752599 | Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof | Adam D. Hughes, Melissa Fleury, Miroslav Rapta, Gene Timothy Fass, Michael Simeone | 2020-08-25 |
| 10548879 | (2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid | Melissa Fleury, Adam D. Hughes, Anne-Marie Beausoleil, Erik Fenster, Miroslav Rapta | 2020-02-04 |
| 10538513 | Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors | Robert Murray McKinnell, Erik Fenster, Tom M. Lam, Jerry Nzerem, Marta Dabros +1 more | 2020-01-21 |
| 10493077 | Fused imidazo-piperidine JAK inhibitor compound | Paul R. Fatheree, Lan Jiang, Marta Dabros, Jerry Nzerem | 2019-12-03 |
| 10494382 | Crystalline solvate comprising 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile, methanol, N-N-dimethylformamide, and water | Xiaojun Huang | 2019-12-03 |
| 10472335 | Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-bipheny]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof | Adam D. Hughes, Melissa Fleury, Miroslav Rapta, R. Michael Baldwin, David L. Bourdet | 2019-11-12 |
| 10392368 | Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors | Erik Fenster, Tom M. Lam, Mandy Loo, Robert Murray McKinnell, Anthony Francesco Palermo +5 more | 2019-08-27 |
| 10369142 | Combination dosage form of a mu opioid receptor antagonist and an opioid agent | Shaoling Li, Manshiu Leung, Hao Zhang, Yun Mo | 2019-08-06 |
| 10251874 | Crystalline forms of a JAK inhibitor compound | Marta Dabros, Jerry Nzerem, Melanie A. Kleinschek, Glenn D. Crater | 2019-04-09 |
| 10183942 | JAK kinase inhibitor compounds for treatment of respiratory disease | Noah Benjamin, Marta Dabros | 2019-01-22 |